NVC-001 / Nuevocor - LARVOL DELTA

SUNBEAM-LMNA: A First-in-Human Phase 1/2 Trial of NVC-001 Gene Therapy in LMNA-Related Dilated Cardiomyopathy [Poster no. CTC-001] (HFSA 2026) - No abstract available

First-in-human • Gene therapy • P1/2 data • Cardiomyopathy • Cardiovascular • Gene Therapies • LMNA

NVC-001 Gene Therapy For The Treatment Of LMNA-Related Dilated Cardiomyopathy [Poster no. 467] (HFSA 2026) - No abstract available

Gene therapy • Cardiomyopathy • Cardiovascular • Gene Therapies • LMNA

A Study With NVC-001 in Patients With LMNA-related Dilated Cardiomyopathy (SUNBEAM-LMNA) (clinicaltrials.gov) - P1/2 | N=21 | Recruiting | Sponsor: Nuevocor Pte. Ltd. | Not yet recruiting ➔ Recruiting

Enrollment open • First-in-human • Cardiomyopathy • Cardiovascular • LMNA